Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             156 results found
no title author magazine year volume issue page(s) type
1 Aberrant expression of alternative DNA polymerases: A source of mutator phenotype as well as replicative stress in cancer Hoffmann, Jean-Sébastien
 2010
 104-105 5 p. 312-319
8 p.
 article
2 Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression Fang, Jennifer S.
 2008
 104-105 5 p. 330-337
8 p.
 article
3 Angiogenesis in malignancy Cao, Yihai
 2009
 104-105 5 p. 277-278
2 p.
 article
4 Announcement 1998
 104-105 5 p. 401-
1 p.
 article
5 Autophagosome formation—The role of ULK1 and Beclin1–PI3KC3 complexes in setting the stage Wirth, Martina
 2013
 104-105 5 p. 301-309
9 p.
 article
6 Autophagy in cellular transformation, survival and communication with the tumor microenvironment Münz, Christian
 2013
 104-105 5 p. 299-300
2 p.
 article
7 Autophagy in tumour cell death Macintosh, Robin L.
 2013
 104-105 5 p. 344-351
8 p.
 article
8 Autophagy proteins regulate cell engulfment mechanisms that participate in cancer Kim, Sung Eun
 2013
 104-105 5 p. 329-336
8 p.
 article
9 Autophagy regulation and its role in cancer Lorin, Séverine
 2013
 104-105 5 p. 361-379
19 p.
 article
10 BRCA1 methylation: a significant role in tumour development? Catteau, Aurélie
 2002
 104-105 5 p. 359-371
13 p.
 article
11 Breast cancer: introduction Ingvarsson, Sigurdur
 2001
 104-105 5 p. 323-326
4 p.
 article
12 Can cancer be reversed by engineering the tumor microenvironment? Ingber, Donald E.
 2008
 104-105 5 p. 356-364
9 p.
 article
13 Cancer development at tissue level Laconi, Ezio
 2008
 104-105 5 p. 303-304
2 p.
 article
14 Cancer prevention with freeze-dried berries and berry components Stoner, Gary D.
 2007
 104-105 5 p. 403-410
8 p.
 article
15 Cancer stem cells and angiogenesis Bjerkvig, Rolf
 2009
 104-105 5 p. 279-284
6 p.
 article
16 Carcinogenesis in Down syndrome: What can be learned from trisomy 21? Satgé, Daniel
 2008
 104-105 5 p. 365-371
7 p.
 article
17 Checking the garbage bin for problems in the house, or how autophagy assists in antigen presentation to the immune system Romao, Susana
 2013
 104-105 5 p. 391-396
6 p.
 article
18 Chemopreventive characteristics of avocado fruit Ding, Haiming
 2007
 104-105 5 p. 386-394
9 p.
 article
19 Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response Peller, Shoshana
 1998
 104-105 5 p. 379-387
9 p.
 article
20 Clinical trials of targeted toxins Frankel, Arthur E.
 1995
 104-105 5 p. 307-317
11 p.
 article
21 Complementation tagging of cooperating oncogenes in knockout mice Allen, John D.
 1996
 104-105 5 p. 299-306
8 p.
 article
22 Could p53 be a target for therapeutic suppression? Komarova, Elena
 1998
 104-105 5 p. 389-400
12 p.
 article
23 CpG island methylator phenotypes in aging and cancer Toyota, Minoru
 1999
 104-105 5 p. 349-357
9 p.
 article
24 Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma Ensoli, Barbara
 2000
 104-105 5 p. 367-381
15 p.
 article
25 Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures Zhang, Shuguang
 2005
 104-105 5 p. 413-420
8 p.
 article
26 3D-extravasation model – selection of highly motile and metastatic cancer cells Brandt, Burkhard
 2005
 104-105 5 p. 387-395
9 p.
 article
27 Dietary histone deacetylase inhibitors: From cells to mice to man Dashwood, Roderick H.
 2007
 104-105 5 p. 363-369
7 p.
 article
28 DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms Feinberg, Andrew P
 2002
 104-105 5 p. 389-398
10 p.
 article
29 DNA methylation and the Epstein–Barr virus Ambinder, Richard F.
 1999
 104-105 5 p. 369-375
7 p.
 article
30 DNA methylation changes in leukaemia Melki, John R
 2002
 104-105 5 p. 347-357
11 p.
 article
31 DNA mismatch repair deficient mice in cancer research Prolla, Tomas A.
 1996
 104-105 5 p. 241-247
7 p.
 article
32 DNA replication fidelity and cancer Preston, Bradley D.
 2010
 104-105 5 p. 281-293
13 p.
 article
33 Drug resistance associated with antiangiogenesis therapy Eikesdal, Hans Petter
 2009
 104-105 5 p. 310-317
8 p.
 article
34 Editorial Board 2009
 104-105 5 p. CO2-
1 p.
 article
35 Editorial Board 2008
 104-105 5 p. CO2-
1 p.
 article
36 Editorial Board 2007
 104-105 5 p. CO2-
1 p.
 article
37 Editorial Board 2010
 104-105 5 p. CO2-
1 p.
 article
38 Editorial Board 2013
 104-105 5 p. CO2-
1 p.
 article
39 Editorial Board 2011
 104-105 5 p. CO2-
1 p.
 article
40 Efficiency of carcinogenesis: Is the mutator phenotype inevitable? Beckman, Robert A.
 2010
 104-105 5 p. 340-352
13 p.
 article
41 Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes Smedby, Karin E.
 2011
 104-105 5 p. 293-298
6 p.
 article
42 Epigenetics wins over genetics: induction of differentiation in tumor cells Lotem, Joseph
 2002
 104-105 5 p. 339-346
8 p.
 article
43 Epigenetic versus genetic alterations in the inactivation of E-cadherin Strathdee, Gordon
 2002
 104-105 5 p. 373-379
7 p.
 article
44 Estrogen receptor and breast cancer Sommer, Stephanie
 2001
 104-105 5 p. 339-352
14 p.
 article
45 Experimental manipulation of genomic methylation Jackson-Grusby, Laurie
 1996
 104-105 5 p. 261-268
8 p.
 article
46 FHIT alterations in breast cancer Ingvarsson, Sigurdur
 2001
 104-105 5 p. 361-366
6 p.
 article
47 From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome Monni, Outi
 2001
 104-105 5 p. 395-401
7 p.
 article
48 Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systems Birgersdotter, Anna
 2005
 104-105 5 p. 405-412
8 p.
 article
49 Genes in the RB pathway and their knockout in mice Lin, Suh-Chin J.
 1996
 104-105 5 p. 279-289
11 p.
 article
50 Genetic epidemiology of female breast cancer Hopper, John L
 2001
 104-105 5 p. 367-374
8 p.
 article
51 Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells Wiendl, Heinz
 2003
 104-105 5 p. 343-351
9 p.
 article
52 HLA-G and IL-10 expression in human cancer—different stories with the same message Urosevic, Mirjana
 2003
 104-105 5 p. 337-342
6 p.
 article
53 HLA-G and lymphoproliferative disorders Amiot, Laurence
 2003
 104-105 5 p. 379-385
7 p.
 article
54 HLA-G in cancer: a way to turn off the immune system Rouas-Freiss, Nathalie
 2003
 104-105 5 p. 325-336
12 p.
 article
55 HLA-G in melanoma: can the current controversies be solved? Chang, Chien-Chung
 2003
 104-105 5 p. 361-369
9 p.
 article
56 HLA-G modulates immune responses by diverse receptor interactions Hofmeister, Valeska
 2003
 104-105 5 p. 317-323
7 p.
 article
57 Human RECQ helicases: Roles in DNA metabolism, mutagenesis and cancer biology Monnat Jr., Raymond J.
 2010
 104-105 5 p. 329-339
11 p.
 article
58 Hypermethylation of tumor suppressor genes in cancer Herman, James G.
 1999
 104-105 5 p. 359-367
9 p.
 article
59 Immunological enhancement of primary tumor development and its prevention Schreiber, Hans
 2000
 104-105 5 p. 351-357
7 p.
 article
60 Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance Cao, Yihai
 2009
 104-105 5 p. 338-343
6 p.
 article
61 Inhibition of carcinogenesis by tea constituents Ju, Jihyeung
 2007
 104-105 5 p. 395-402
8 p.
 article
62 Integrins as “functional hubs” in the regulation of pathological angiogenesis Contois, Liangru
 2009
 104-105 5 p. 318-328
11 p.
 article
63 Interaction between host T cells and Reed–Sternberg cells in Hodgkin lymphomas Poppema, Sibrand
 2000
 104-105 5 p. 345-350
6 p.
 article
64 Interindividual differences in phytochemical metabolism and disposition Lampe, Johanna W.
 2007
 104-105 5 p. 347-353
7 p.
 article
65 Introduction Rotter, Varda
 1998
 104-105 5 p. 315-316
2 p.
 article
66 Introduction Zhang, Shuguang
 2005
 104-105 5 p. 327-328
2 p.
 article
67 Introduction Baylin, Stephen B.
 1999
 104-105 5 p. 327-328
2 p.
 article
68 Introduction: genetic and epigenetic contributions to tumor evolution Klein, George
 2002
 104-105 5 p. 327-330
4 p.
 article
69 Introduction: Mutant mice in cancer research Bradley, Allan
 1996
 104-105 5 p. 227-228
2 p.
 article
70 Introduction: Therapy targeted to surface antigens and receptors (I) Fitzgerald, David
 1995
 104-105 5 p. 257-
1 p.
 article
71 Invasion emerges from cancer cell adaptation to competitive microenvironments: Quantitative predictions from multiscale mathematical models Quaranta, Vito
 2008
 104-105 5 p. 338-348
11 p.
 article
72 In vitro and in vivo imaging of cell migration: Two interdepending methods to unravel metastasis formation Palm, Daniel
 2005
 104-105 5 p. 396-404
9 p.
 article
73 Knockout mouse models and mammary tumorigenesis Deng, Chu-Xia
 2001
 104-105 5 p. 387-394
8 p.
 article
74 Lethal Mutagenesis: Targeting the Mutator Phenotype in Cancer Fox, Edward J.
 2010
 104-105 5 p. 353-359
7 p.
 article
75 Macrophage polarization in tumour progression Sica, Antonio
 2008
 104-105 5 p. 349-355
7 p.
 article
76 Manipulation of the mouse germline in the study of Min -induced neoplasia Bilger, Andrea
 1996
 104-105 5 p. 249-260
12 p.
 article
77 Mantle cell lymphoma Sander, Birgitta
 2011
 104-105 5 p. 291-292
2 p.
 article
78 Matrigel: Basement membrane matrix with biological activity Kleinman, Hynda K.
 2005
 104-105 5 p. 378-386
9 p.
 article
79 Mechanisms underlying epigenetically mediated gene silencing in cancer Baylin, Stephen B
 2002
 104-105 5 p. 331-337
7 p.
 article
80 Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Walle, Thomas
 2007
 104-105 5 p. 354-362
9 p.
 article
81 Ménage à Trois in stress: DAMPs, redox and autophagy Li, Guanqiao
 2013
 104-105 5 p. 380-390
11 p.
 article
82 Modeling dynamic reciprocity: Engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation Nelson, Celeste M.
 2005
 104-105 5 p. 342-352
11 p.
 article
83 Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis Wu, Lizi
 2004
 104-105 5 p. 348-356
9 p.
 article
84 Modulation of the autophagy pathway by human tumor viruses Silva, Lindsey M.
 2013
 104-105 5 p. 323-328
6 p.
 article
85 Molecular and pathological characterization of inherited breast cancer Borg, Åke
 2001
 104-105 5 p. 375-385
11 p.
 article
86 Mouse models dissect the role of p53 in cancer and development Lozano, Guillermina
 1998
 104-105 5 p. 337-344
8 p.
 article
87 Mutator phenotype in cancer: Origin and consequences Loeb, Lawrence A.
 2010
 104-105 5 p. 279-280
2 p.
 article
88 Mutator phenotypes due to DNA replication infidelity Arana, Mercedes E.
 2010
 104-105 5 p. 304-311
8 p.
 article
89 Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation Ruggeri, Loredana
 2006
 104-105 5 p. 404-411
8 p.
 article
90 Natural killer cells in cancer Höglund, Petter
 2006
 104-105 5 p. 331-332
2 p.
 article
91 New molecular targets in mantle cell lymphoma Parekh, Samir
 2011
 104-105 5 p. 335-346
12 p.
 article
92 Nf1 gene targeting: toward models and mechanisms Cichowski, Karen
 1996
 104-105 5 p. 291-298
8 p.
 article
93 NK cell activating ligands on human malignant cells: Molecular and functional defects and potential clinical relevance Chang, Chien-Chung
 2006
 104-105 5 p. 383-392
10 p.
 article
94 Notch and T cell malignancy Zweidler-McKay, Patrick A
 2004
 104-105 5 p. 329-340
12 p.
 article
95 Notch in lung development and lung cancer Collins, Brendan J
 2004
 104-105 5 p. 357-364
8 p.
 article
96 Notch in mammary gland development and breast cancer Politi, Katerina
 2004
 104-105 5 p. 341-347
7 p.
 article
97 Notch signaling and cancer: emerging complexity Axelson, Håkan
 2004
 104-105 5 p. 317-319
3 p.
 article
98 Notch signaling in development and disease Hansson, Emil M
 2004
 104-105 5 p. 320-328
9 p.
 article
99 Notch signaling in neuroblastoma Påhlman, Sven
 2004
 104-105 5 p. 365-373
9 p.
 article
100 Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression Lefort, Karine
 2004
 104-105 5 p. 374-386
13 p.
 article
101 Novel approaches using natural killer cells in cancer therapy Suck, Garnet
 2006
 104-105 5 p. 412-418
7 p.
 article
102 Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells Pantel, Klaus
 2001
 104-105 5 p. 327-337
11 p.
 article
103 Oxidative breakage of cellular DNA by plant polyphenols: A putative mechanism for anticancer properties Hadi, S.M.
 2007
 104-105 5 p. 370-376
7 p.
 article
104 p53 and apoptosis Gottlieb, Tanya M.
 1998
 104-105 5 p. 359-368
10 p.
 article
105 Passenger mutations as a marker of clonal cell lineages in emerging neoplasia Salk, Jesse J.
 2010
 104-105 5 p. 294-303
10 p.
 article
106 p53-Dependent cell cycle control: response to genotoxic stress Schwartz, Dov
 1998
 104-105 5 p. 325-336
12 p.
 article
107 Phytonutrients: A more natural approach toward cancer prevention D’Ambrosio, Steven M.
 2007
 104-105 5 p. 345-346
2 p.
 article
108 Pomegranate derived products for cancer chemoprevention Syed, Deeba N.
 2007
 104-105 5 p. 377-385
9 p.
 article
109 Positive and negative regulation of Natural Killer cells: Therapeutic implications Hallett, William H.D.
 2006
 104-105 5 p. 367-382
16 p.
 article
110 Progress of HLA-G in cancer Carosella, Edgardo D.
 2003
 104-105 5 p. 315-316
2 p.
 article
111 Reactivation of mutant p53: a new strategy for cancer therapy Selivanova, Galina
 1998
 104-105 5 p. 369-378
10 p.
 article
112 Regulation of autophagy by stress-responsive transcription factors Pietrocola, Federico
 2013
 104-105 5 p. 310-322
13 p.
 article
113 Regulation ofp53downstream genes El-Deiry, Wafik S.
 1998
 104-105 5 p. 345-357
13 p.
 article
114 Relationships between chromatin organization and DNA methylation in determining gene expression Jones, Peter L.
 1999
 104-105 5 p. 339-347
9 p.
 article
115 Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas Ponzio, Nicholas M
 2000
 104-105 5 p. 331-340
10 p.
 article
116 Reverse immune surveillance: an adaptive mechanism used by tumor cells to facilitate their survival and growth. Editorial overview Thorbecke, G.Jeanette
 2000
 104-105 5 p. 327-330
4 p.
 article
117 Role of activated host T cells in the promotion of MALT lymphoma growth Guindi, M
 2000
 104-105 5 p. 341-344
4 p.
 article
118 Role of genetic and epigenetic changes in Burkitt lymphoma Lindström, Mikael S
 2002
 104-105 5 p. 381-387
7 p.
 article
119 Secretion of sHLA-G molecules in malignancies Rebmann, Vera
 2003
 104-105 5 p. 371-377
7 p.
 article
120 Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression Beacham, Dorothy A.
 2005
 104-105 5 p. 329-341
13 p.
 article
121 Targeted therapy of carcinomas using BR96 sFv-PE40, a single-chain immunotoxin that binds to the Leyantigen Siegall, Clay B.
 1995
 104-105 5 p. 289-295
7 p.
 article
122 Targeting autophagy as a potential therapeutic approach for melanoma therapy Liu, He
 2013
 104-105 5 p. 352-360
9 p.
 article
123 Targeting diphtheria toxin to growth factor receptors Murphy, John R.
 1995
 104-105 5 p. 259-267
9 p.
 article
124 Targeting plant toxins to the urokinase and α2-macroglobulin receptors Cavallaro, Ugo
 1995
 104-105 5 p. 269-278
10 p.
 article
125 Targeting Pseudomonas exotoxin to hematologic malignancies Kreitman, Robert J.
 1995
 104-105 5 p. 297-306
10 p.
 article
126 The angiogenic switch in carcinogenesis Baeriswyl, Vanessa
 2009
 104-105 5 p. 329-337
9 p.
 article
127 The complex landscape of genetic alterations in mantle cell lymphoma Royo, Cristina
 2011
 104-105 5 p. 322-334
13 p.
 article
128 The DNA damage response, immunity and cancer Gasser, Stephan
 2006
 104-105 5 p. 344-347
4 p.
 article
129 The dynamics of natural killer cell tolerance Johansson, Maria H.
 2006
 104-105 5 p. 393-403
11 p.
 article
130 The establishment and maintenance of DNA methylation patterns in mouse somatic cells Turker, Mitchell S.
 1999
 104-105 5 p. 329-337
9 p.
 article
131 The functional role of cell adhesion molecules in tumor angiogenesis Francavilla, Chiara
 2009
 104-105 5 p. 298-309
12 p.
 article
132 The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies Burger, Jan A.
 2011
 104-105 5 p. 308-312
5 p.
 article
133 The microenvironments of multistage carcinogenesis Laconi, Ezio
 2008
 104-105 5 p. 322-329
8 p.
 article
134 The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer Klenova, Elena M
 2002
 104-105 5 p. 399-414
16 p.
 article
135 Theories of carcinogenesis: An emerging perspective Sonnenschein, Carlos
 2008
 104-105 5 p. 372-377
6 p.
 article
136 The p53-deficient mouse: a model for basic and applied cancer studies Donehower, Lawrence A.
 1996
 104-105 5 p. 269-278
10 p.
 article
137 The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas Wasik, Agata M.
 2011
 104-105 5 p. 313-321
9 p.
 article
138 The role of HLA-G for protection of human renal cell–carcinoma cells from immune-mediated lysis: implications for immunotherapies Bukur, Jürgen
 2003
 104-105 5 p. 353-359
7 p.
 article
139 The role of human and viral cytokines in the pathogenesis of multiple myeloma Berenson, James R
 2000
 104-105 5 p. 383-391
9 p.
 article
140 The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance Fuchs, Anja
 2006
 104-105 5 p. 359-366
8 p.
 article
141 The role of the NKG2D receptor for tumor immunity Coudert, Jérôme D.
 2006
 104-105 5 p. 333-343
11 p.
 article
142 Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone Wang, Ruoxiang
 2005
 104-105 5 p. 353-364
12 p.
 article
143 Three-dimensional tissue culture models in cancer biology Kim, Jong Bin
 2005
 104-105 5 p. 365-377
13 p.
 article
144 TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis Olivier, Magali
 2001
 104-105 5 p. 353-360
8 p.
 article
145 Transcriptional regulation of the p53 tumor suppressor gene Reisman, David
 1998
 104-105 5 p. 317-324
8 p.
 article
146 Tumor and viral recognition by natural killer cells receptors Arnon, Tal I.
 2006
 104-105 5 p. 348-358
11 p.
 article
147 Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF) Mitchell, Robert A
 2000
 104-105 5 p. 359-366
8 p.
 article
148 Tumor lymphatics Sleeman, Jonathan
 2009
 104-105 5 p. 285-297
13 p.
 article
149 Tumor targeting through fibroblast growth factor receptors Lappi, Douglas A.
 1995
 104-105 5 p. 279-288
10 p.
 article
150 Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: Implications for the origin and selection of the malignant cells Agathangelidis, Andreas
 2011
 104-105 5 p. 299-307
9 p.
 article
151 Unraveling the microenvironmental influences on the normal mammary gland and breast cancer Weigelt, Britta
 2008
 104-105 5 p. 311-321
11 p.
 article
152 Using microarrays to study the microenvironment in tumor biology: The crucial role of statistics Baker, Stuart G.
 2008
 104-105 5 p. 305-310
6 p.
 article
153 Variant base excision repair proteins: Contributors to genomic instability Nemec, Antonia A.
 2010
 104-105 5 p. 320-328
9 p.
 article
154 Viral interactions with the Notch pathway Hayward, S.Diane
 2004
 104-105 5 p. 387-396
10 p.
 article
155 Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications Corazzari, Marco
 2013
 104-105 5 p. 337-343
7 p.
 article
156 Xpa knockout mice de Vries, Annemieke
 1996
 104-105 5 p. 229-240
12 p.
 article
                             156 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands